Bristol-Myers says FDA approves new 300mg loading dose tablet for Plavix

Thu Sep 27, 2007 9:00am EDT

Share

[-] Text [+]

Sanofi-aventis (SNY) and BMY announce that the FDA has approved a supplemental new drug applicatio for a 300mg tablet of the antiplatelet Plavix.

Share:

also on reuters

Maria von Trapp returns to "Sound of Music" home

Top EU court backs citizen rights in air pollution

It's art, for the Facebook generation

Featured Broker sponsored link

Editor's Choice

A selection of our best photos from the past 24 hours. View Slideshow

Most Popular on Reuters

New York Photo Awards Multimedia Winner

Bearing Witness
Reuters award-winning multimedia piece, reflecting five years of reporting the war in Iraq.

Watch now

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Reuters Widgets